Gilead Sciences (GILD) Tops Q1 EPS by 31c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $153.79 -1.74%
EPS Growth %: -12.1%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: -12.1%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $2.12, $0.31 better than the analyst estimate of $1.81. Revenue for the quarter came in at $6.6 billion versus the consensus estimate of $6.28 billion.
GUIDANCE:
Gilead Sciences sees Q2 2022 EPS of $6.20-$6.70, versus the consensus of $6.50. Gilead Sciences sees Q2 2022 revenue of $23.8-24.3 billion, versus the consensus of $24.48 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Equity Lifestyle Properities (ELS) Misses Q3 EPS by 6c; Offers Guidance
- AT&T (T) Tops Q3 EPS by 5c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
